was administered to rats for 2 weeks, and serum lipoprotein lipid levels, platelet aggregation, and lipid metabolism in the aorta in vivo were investigated. 20:5 (n-3) decreased the level of low density lipoprotein phospholipid. 22:6 (n-3) increased the level of high density lipoprotein cholesterol and decreased those of low density lipoprotein triglyceride and phospholipid. Both 20:5 (n-3) and 22:6 (n-3) markedly inhibited platelet aggreation. 20:5 (n-3) decreased the acid and neutral cholesterol esterase activities, but did not affect either aryl-CoA synthetase or acyl-CoA: cholesterol acyltransferase activity. 22:6 (n-3) had no effect on any of these enzyme activities. From these results, the roles of 20:5 (n-3) and 22:6 (n-3) in the formation of atheromatous lesions and the mechanism of the decrease in cholesterol esterase activity by 20:5 (n-3) were discussed. polyunsaturated fatty acid; platelet aggregation; cholesterol esterase; acyl-CoA synthetase; acyl-CoA: cholesterol acyltransferase
Greenland Eskimos have a very low incidence of ischemic heart disease. From early studies, favorable plasma lipid and lipoprotein concentrations were considered to be partly responsible for their low incidence of ischemic heart disease (Bang et al. 1971 ; Bang and Dyerberg 1972; Dyerberg et al. 1977) . Recently, more attention has been paid to a specific polyunsaturated fatty acid, cis-5,8,11,14,17-eicosapentaenoic acid (n-3) (EPA). In Greenland Eskimos the EPA concentration is high in plasma lipids (Dyerberg et al. 1975 ) and platelets (Dyerberg and Bang 1979) . EPA inhibits aggregation of platelets in vitro (Dyerberg and Bang 1978; Whitaker et al. 1979; Needleman et al. 1979 ; Gryglewski et al. 1979 in platelet aggregation compared with age-and sex-matched Danish controls (Dyerberg and Bang 1979) . The high amount of EPA in Greenland Eskimos is considered to be derived from their marine foods (Bang et al. 1976 ). Thus EPA has been suggested to be antiatherosclerotic because of its anti-aggregatory effect on platelets. However, the diet of the Eskimos is also rich in another polyunsaturated fatty acid, i.e., cis-4,7, 10,13,16,1 9-docosahexaenoic acid (n-3) (DHA) and monounsaturated fatty acids (C20:1, C22:1 and C24:1) (Bang et al. 1976 ) and consequently, the concentrations of these fatty acids are also high in their platelets (Dyerberg and Bang 1979) . DHA was reported to inhibit cyclooxygenase (Needleman et al. 1976; Lands et al. 1973) , and thus it may also inhibit platelet aggregation. Thus it could also be a cuase of the reduced platelet aggregation of Greenland Eskimos. Although there have been many experiments on the effect of foods rich in these n- In the present study, purified EPA and DHA were administered to rats for 2 weeks and the effects of these fatty acids on (i) serum lipoprotein lipids, (ii) platelet aggregation and (iii) lipid metabolism in the aorta were examined because these three processes are thought to be important in development of atherosclerosis. Feeding conditions. Male Wistar-King strain rats weighing about 250 g were given CMF chow (Oriental Kobo Co. Ltd., Tokyo) ad libitum for 2 weeks. EPA or DHA ethyl ester was administered at 100 mg/rat in 50 ml of emulsion during the night. This emulsion was carefully prepared just before administration each evening to avoid peroxidation. The following morning the 50 ml of emulsion was confirmed to have been consumed by each rat. During the daytime, animals had free access to water. Each group consisted of 10 animals.
Preparation of samples. Rats were starved for 18 hr and then anesthetized with ethylether. The abdominal wall was opened and blood was collected from the inferior vena cava. Blood of 5 animals in each group was pooled for lipid analysis. Blood of the other 5 animals in each group was used for measuring platelet aggregation.
For this, 9 volume of blood was mixed with one volume of 3.8% sodium citrate in a plastic centrifuge tube, the mixture was centrifuged for 10 min at 250 x g, and the upper layer was used as plateletrich plasma.
Platelet-poor plasma was obtained by centrifuging the remaining contents of the tube for 20 min at 800 x g. The aorta from the aortic arch to the iliac bifurcation was quickly removed and placed on ice. Enzyme solution was prepared from the aorta as reported previously ( Analysis of serum lipids. Serum was fractionated by ultracentrifugation in a LP-42Ti rotor (Beckman Instruments, Inc., Cal. 92634, USA). The tube containing 175 yl of serum adjusted to a density of 1.006 (tube A) or 1.063 (tube B) with KBr was centrifuged at 225,000 x g for 150 min and then the upper phase was aspirated.
The remaining fraction was adjusted to its original volume by adding saline and its lipid content was measured. Tubes A and B after centrifugation and aspiration contained low density lipoprotein (LDL) and high density lipoprotein (HDL) or HDL alone, respectively.
The amounts of lipoprotein fractions were calculated as follows: HDL, content of tube B; LDL, content of tube A -content of tube B; VLDL, content of whole serum -content of tube A.
Cholesterol was assayed enzymatically with cholesteryl ester hydrolase, cholesterol oxidase and peroxidase (Allain 1974) . Triglyceride was measured enzymatically with lipoprotein lipase, glycerol dehydrogenase and diaphorase (Tiffany 1974) . Phospholipid was assayed enzymatically with phospholipase D and choline oxidase (Takayama 1977 ). Statistics. Statistical significances of differences between means were evaluated by Student's t-test.
RESULTS

Animal conditions
The body weights of groups treated with EPA and DHA were sig higher than that of controls, but their liver weights were not sig different from that of controls (Table 1 Table 2 shows the serum lipid levels of whole serum and lipoprotein fractions. The total cholesterol levels in the three groups were not significantly different. However, the HDL-cholesterol level in the DHA-treated group was slightly (10.6 %) but significantly higher than that of controls. The LDL-and VLDL-cholesterol levels and the triglyceride level were not significantly different in the three groups. In the lipoprotein fractions, only the LDL-triglyceride level of the DHA-treated group was significantly decreased. The mean value for phospholipid in the DHAtreated group was 11% more than that of controls, but this difference was not significant. The LDL-phospholipid levels in the EPA-and DHA-treated groups were significantly lower than that of controls. The free fatty acid levels of the three groups were not significantly different.
Platelet aggregation.
The platelet counts in the three groups were not significantly different; that is, (1.22±0.08) X 106/mm3 for the control group, (1.22±0.28) X 106/mm3 for the EPA group, and (1.33±0.13) X 106/mm3 for the DHA group. However, platelet aggregations stimulated by 15 µg/ml collagen or 5 , tM ADP in the EPA-and Enzyme activities in the aorta.
Acid and neutral cholesterol esterase activities were significantly EPA group, but not the DHA group, than in the control group (Table  activities related (Table 2) . However, the increase in the HDL-cholesterol level observed in the DHA group (Table 2) may be favorable for atherosclerosis, since HDLcholesterol was considered to be a negative risk factor of atherosclerosis (Gordon et al. 1977; Miller and Miller 1975) . The significance of the decreases in the levels of LDL-triglyceride and LDL-phospholipid observed in the EPA and DHA groups in development of atherosclerosis are not yet known. Greenland Eskimos, who eat marine foods rich in EPA, DHA, and long chain mono-unsaturated fatty acids (020:1, 022:1, and 024:1) (Bang et al. 1976 ) have lower plasma concentrations of total cholesterol, triglycerides, 9-lipoproteins, and pre-3-lipoproteins, than ageand sex-matched Danish subjects (Bang et al. 1971 ; Bang and Dyerberg 1972; Dyerberg et al. 1977 ). Moreover, administration of a fish diet rich in EPA, DHA and long chain mono-unsaturated fatty acids to humans decreased serum total cholesterol, triglycerides and VLDL, and increased HDL-cholesterol (von Lossonczy et al. 1978). Judging from the present results, these effects of marine foods or oils cannot be explained by the effect of EPA or DHA alone; the long-term effects of long chain mono-unsaturated fatty acids such as 020:1, 022:1, and 024:1 must also be considered. The difference of species also should be taken into account.
The thrombogenic theory of atherosclerosis has been well discussed by a number of investigators (Mustard et al. 1977; Harker et al. 1978; Stemerman 1979) . The low incidence of atherosclerosic diseases in Greenland Eskimos has been discussed from this point of view Bang 1978, 1979 In these reports reduction of platelet aggregation in Greenland Eskimos was attributed to a high intake of EPA and a high concentration of EPA in their platelets. However, the present study showed that EPA and DHA, which are both present at high concentrations in Eskimos diets (Bang et al. 1976 ) reduce platelet aggregation (Table 3) (neutral cholesterol esterase) ; these enzymes are thought to be located in lysosomes and microsomes, respectively (Shinomiya et al. 1979 ). For synthesis of cholesterol esters in the aorta, two enzymes are necessary; first, free fatty acid is activated by aryl-CoA synthetase and then incoporation of acyl-CoA into cholesterol is catalyzed by acyl-CoA : cholesterol acyltransferase.
These enzyme activities were mainly located in microsomes in the aorta of rats (Morisaki et al. 1980; Shirai et al. 1980 ). In the present study, the activities of acyl-CoA synthetase and acyl-CoA: cholesterol acyltransferase were not changed by EPA or DHA administration (Table 4) . However, both acid and neutral cholesterol esterase activities were significantly decreased by EPA. This suggests that EPA stimulates the accumulation of cholesterol esters both in lysosomes and microsomes if the incorporation of cholesterol esters (or LDL) is the same in the control and EPA-treated groups. DHA did not change the cholesterol esterase activity significantly (Table 4 ).
The mechanism of regulation of cholesterol esterase activity is not well known. In in vivo experiments, cholesterol esterase activities were decreased in tocopherol deficiency (Shirai et al. 1980; Murano et al. 1982 ) and in highly developed atheromatous lesions induced by hypothyroidism, vitamin D2 and high cholesterol diets (Morisaki et al. 1982) . In these conditions, the membrane properties in cells of the aorta were considered to be greatly changed. As cholesterol esterase is a membrane bound enzyme (Takano et al. 1974; Shinomiya et al. 1979) , its activity may well be affected by qualitative and quantitative changes in lipids. In fact, it was found that phosphatidylcholine and phosphatidylethanolamine increased the enzyme activity and sphingomyelin decreased it (Shinomiya et al. 1979 ). In addition the composition of the substrate mixture of the enzyme affected the enzyme activity in a very complex manner (Shinomiya et al. 1981) . EPA administration may change the membrane properties of cells in the aorta and may affect the activity of cholesterol esterase. Another possibility is that EPA may affect cholesterol esterase activity by changing prostanoid metabolism. EPA could be a precursor of P013, which has a similar effect on platelet aggregation and vasodilation to PGI2 (Needleman et al. 1979; Smith et al . 1979 ). However, Hornstra et al. (1981) and Scherhag et al. (1982) failed to obtain any evidence for in vivo conversion of EPA to PGI3 in rats in which the EPA level was elevated by cod liver oil. On the contrary, cod liver oil feeding resulted in low PGI2-like activity in the aorta of rats (Hornstra et al. 1981; Scherhag et al. 1982) . Increased production of PGI2 was positively correlated with cholesterol esterase activity. It is likely that EPA administration decreased PGI2 in the aorta and decreased cholesterol esterase activity. Investigations are now in progress to clarify the mechanism regulating lipid metabolism in the serum and aorta. 
